companydata.dkcompanydata.dk

BIODANE PHARMA A/S: Financial statements 2025

CVR: 28310102

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

BIODANE PHARMA A/S (CVR 28310102) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 2,534,166 and a net result of DKK 182,862 compared with DKK 1,651,356 the year before. That is a decrease of 12.2% compared with the year before. Equity in the 2025 report amounted to DKK 2,505,002. The solvency ratio was 67.6%.

Gross Profit
DKK 2,534,166
Profit/Loss
DKK 182,862
Equity
DKK 2,505,002
Total Assets
DKK 3,704,529
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-2.5 mio.183 t.2.5 mio.0
2024-2.9 mio.1.7 mio.2.3 mio.1
2023-3.1 mio.900 t.3.5 mio.1
2022-2.4 mio.586 t.4.6 mio.1
2021-3.7 mio.1.9 mio.4.1 mio.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is BIODANE PHARMA A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

BIODANE PHARMA A/S: The 2024 annual report is outMay 23, 2025

BIODANE PHARMA A/S has published its annual report for 2024. Gross profit came to DKK 2,886,145, and the net result was DKK 1,651,356.

About BIODANE PHARMA A/S

BIODANE PHARMA A/S is a Danish company of the type Aktieselskab based in Gesten, founded in 2004. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named BIODANE PHARMA ApS and BIOFIBER TØRRING ApS. The management consists of Gunner Kreutzer Jakobsen. The board consists of Peter Gæmelke (chair), Flemming Torben Heden Knudsen, Gunner Kreutzer Jakobsen and Rasmus Juhl Rasmussen. The company is owned by BIODAN A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 2,534,166 and a net result of DKK 182,862 compared with DKK 1,651,356 the year before. Equity in the 2025 report amounted to DKK 2,505,002.

Source: annual report 2025, Danish Business Authority